• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结核分枝杆菌InhA的慢发性抑制:通过分子动力学模拟揭示停留时间的分子决定因素

Slow-Onset Inhibition of Mycobacterium tuberculosis InhA: Revealing Molecular Determinants of Residence Time by MD Simulations.

作者信息

Merget Benjamin, Sotriffer Christoph A

机构信息

Institute of Pharmacy and Food Chemistry, University of Würzburg, Am Hubland, D-97074, Würzburg, Germany.

出版信息

PLoS One. 2015 May 21;10(5):e0127009. doi: 10.1371/journal.pone.0127009. eCollection 2015.

DOI:10.1371/journal.pone.0127009
PMID:25996598
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4440617/
Abstract

An important kinetic parameter for drug efficacy is the residence time of a compound at a drug target, which is related to the dissociation rate constant koff. For the essential antimycobacterial target InhA, this parameter is most likely governed by the ordering of the flexible substrate binding loop (SBL). Whereas the diphenyl ether inhibitors 6PP and triclosan (TCL) do not show loop ordering and thus, no slow-binding inhibition and high koff values, the slightly modified PT70 leads to an ordered loop and a residence time of 24 minutes. To assess the structural differences of the complexes from a dynamic point of view, molecular dynamics (MD) simulations with a total sampling time of 3.0 µs were performed for three ligand-bound and two ligand-free (perturbed) InhA systems. The individual simulations show comparable conformational features with respect to both the binding pocket and the SBL, allowing to define five recurring conformational families. Based on their different occurrence frequencies in the simulated systems, the conformational preferences could be linked to structural differences of the respective ligands to reveal important determinants of residence time. The most abundant conformation besides the stable EI* state is characterized by a shift of Ile202 and Val203 toward the hydrophobic pocket of InhA. The analyses revealed potential directions for avoiding this conformational change and, thus, hindering rapid dissociation: (1) an anchor group in 2'-position of the B-ring for scaffold stabilization, (2) proper occupation of the hydrophobic pocket, and (3) the introduction of a barricade substituent in 5'-position of the diphenyl ether B-ring.

摘要

药物疗效的一个重要动力学参数是化合物在药物靶点的停留时间,它与解离速率常数koff相关。对于必需的抗分枝杆菌靶点InhA,这个参数很可能由柔性底物结合环(SBL)的排序决定。而二苯醚抑制剂6PP和三氯生(TCL)不会使环发生排序,因此,不会出现慢结合抑制和高koff值,稍微修饰的PT70会导致环有序排列,停留时间为24分钟。为了从动力学角度评估复合物的结构差异,对三个配体结合和两个无配体(受干扰)的InhA系统进行了总采样时间为3.0微秒的分子动力学(MD)模拟。单独的模拟显示,结合口袋和SBL的构象特征具有可比性,从而可以定义五个重复出现的构象家族。根据它们在模拟系统中的不同出现频率,构象偏好可以与各自配体的结构差异联系起来,以揭示停留时间的重要决定因素。除了稳定的EI*状态外,最丰富的构象的特征是Ile202和Val203向InhA的疏水口袋移动。分析揭示了避免这种构象变化从而阻碍快速解离的潜在方向:(1)在B环的2'-位有一个锚定基团以稳定支架,(2)适当占据疏水口袋,以及(3)在二苯醚B环的5'-位引入一个屏障取代基。

相似文献

1
Slow-Onset Inhibition of Mycobacterium tuberculosis InhA: Revealing Molecular Determinants of Residence Time by MD Simulations.结核分枝杆菌InhA的慢发性抑制:通过分子动力学模拟揭示停留时间的分子决定因素
PLoS One. 2015 May 21;10(5):e0127009. doi: 10.1371/journal.pone.0127009. eCollection 2015.
2
Molecular dynamics-based investigation of InhA substrate binding loop for diverse biological activity of direct InhA inhibitors.基于分子动力学的InhA底物结合环对直接InhA抑制剂多种生物活性的研究。
J Biomol Struct Dyn. 2016 Nov;34(11):2434-52. doi: 10.1080/07391102.2015.1118410. Epub 2016 May 20.
3
Insights into the bonding pattern for characterizing the open and closed state of the substrate-binding loop in Mycobacterium tuberculosis InhA.深入了解结核分枝杆菌 InhA 底物结合环开环和闭环状态的键合模式。
Future Med Chem. 2014 Apr;6(6):605-16. doi: 10.4155/fmc.14.27.
4
Multiple receptor conformers based molecular docking study of fluorine enhanced ethionamide with mycobacterium enoyl ACP reductase (InhA).基于多受体构象体的氟增强乙硫异烟胺与结核分枝杆菌烯酰酰基载体蛋白还原酶(InhA)的分子对接研究
J Mol Graph Model. 2017 Oct;77:386-398. doi: 10.1016/j.jmgm.2017.09.010. Epub 2017 Sep 14.
5
A slow, tight binding inhibitor of InhA, the enoyl-acyl carrier protein reductase from Mycobacterium tuberculosis.一种缓慢、紧密结合的 InhA 抑制剂,来自结核分枝杆菌的烯酰基辅酶 A 还原酶。
J Biol Chem. 2010 May 7;285(19):14330-7. doi: 10.1074/jbc.M109.090373. Epub 2010 Mar 3.
6
Rational design of InhA inhibitors in the class of diphenyl ether derivatives as potential anti-tubercular agents using molecular dynamics simulations.利用分子动力学模拟对二苯醚衍生物类InhA抑制剂进行合理设计,作为潜在的抗结核药物。
SAR QSAR Environ Res. 2014;25(6):473-88. doi: 10.1080/1062936X.2014.898690. Epub 2014 Apr 30.
7
Investigating the structural basis of arylamides to improve potency against M. tuberculosis strain through molecular dynamics simulations.通过分子动力学模拟研究芳酰胺的结构基础,以提高对结核分枝杆菌菌株的效力。
Eur J Med Chem. 2010 Dec;45(12):5585-93. doi: 10.1016/j.ejmech.2010.09.008. Epub 2010 Sep 17.
8
A structural and energetic model for the slow-onset inhibition of the Mycobacterium tuberculosis enoyl-ACP reductase InhA.结核分枝杆菌烯酰-ACP还原酶InhA慢发性抑制的结构与能量模型
ACS Chem Biol. 2014 Apr 18;9(4):986-93. doi: 10.1021/cb400896g. Epub 2014 Mar 10.
9
Structure-Based Design and in Silico Screening of Virtual Combinatorial Library of Benzamides Inhibiting 2-trans Enoyl-Acyl Carrier Protein Reductase of with Favorable Predicted Pharmacokinetic Profiles.基于结构的设计和虚拟组合文库的计算机筛选苯甲酰胺抑制 2-反式烯酰基辅酶 A 还原酶与有利的预测药代动力学特征。
Int J Mol Sci. 2019 Sep 24;20(19):4730. doi: 10.3390/ijms20194730.
10
Pyrrolidinone and pyrrolidine derivatives: Evaluation as inhibitors of InhA and Mycobacterium tuberculosis.吡咯烷酮和吡咯烷衍生物:作为InhA和结核分枝杆菌抑制剂的评估
Eur J Med Chem. 2016 Nov 10;123:462-475. doi: 10.1016/j.ejmech.2016.07.028. Epub 2016 Jul 16.

引用本文的文献

1
Is Mycobacterial InhA a Suitable Target for Rational Drug Design?分枝杆菌InhA是合理药物设计的合适靶点吗?
ChemMedChem. 2025 Jul 1;20(13):e202500079. doi: 10.1002/cmdc.202500079. Epub 2025 Apr 29.
2
Rethinking the MtInhA tertiary and quaternary structure flexibility: a molecular dynamics view.重新思考 MtInhA 的三级和四级结构的柔韧性:分子动力学视角。
J Mol Model. 2022 May 10;28(6):140. doi: 10.1007/s00894-022-05135-6.
3
A Long Residence Time Enoyl-Reductase Inhibitor Explores an Extended Binding Region with Isoenzyme-Dependent Tautomer Adaptation and Differential Substrate-Binding Loop Closure.

本文引用的文献

1
Time-dependent diaryl ether inhibitors of InhA: structure-activity relationship studies of enzyme inhibition, antibacterial activity, and in vivo efficacy.时间依赖性二芳基醚抑制剂 InhA:酶抑制、抗菌活性和体内疗效的结构-活性关系研究。
ChemMedChem. 2014 Apr;9(4):776-91. doi: 10.1002/cmdc.201300429. Epub 2014 Mar 11.
2
A structural and energetic model for the slow-onset inhibition of the Mycobacterium tuberculosis enoyl-ACP reductase InhA.结核分枝杆菌烯酰-ACP还原酶InhA慢发性抑制的结构与能量模型
ACS Chem Biol. 2014 Apr 18;9(4):986-93. doi: 10.1021/cb400896g. Epub 2014 Mar 10.
3
Rational optimization of drug-target residence time: insights from inhibitor binding to the Staphylococcus aureus FabI enzyme-product complex.
一种长停留时间烯酰还原酶抑制剂通过同工酶依赖性互变异构适应和不同的底物结合环闭合来探索扩展结合区域。
ACS Infect Dis. 2021 Apr 9;7(4):746-758. doi: 10.1021/acsinfecdis.0c00437. Epub 2021 Mar 12.
4
The importance of the quaternary structure to represent conformational ensembles of the major Mycobacterium tuberculosis drug target.四级结构对代表主要结核分枝杆菌药物靶点构象集合的重要性。
Sci Rep. 2019 Sep 23;9(1):13683. doi: 10.1038/s41598-019-50213-0.
5
Utilizing the Combination of Binding Kinetics and Micro-Pharmacokinetics Link in Vitro α-Glucosidase Inhibition to in Vivo Target Occupancy.利用结合动力学和微药代动力学关联,将体外α-葡萄糖苷酶抑制作用与体内靶部位占有率联系起来。
Biomolecules. 2019 Sep 16;9(9):493. doi: 10.3390/biom9090493.
6
Examining the role of protein structural dynamics in drug resistance in .研究蛋白质结构动力学在……中耐药性方面的作用。 (注:原文结尾处“in”后面内容缺失)
Chem Sci. 2017 Dec 1;8(12):8384-8399. doi: 10.1039/c7sc03336b. Epub 2017 Oct 16.
7
Screening of a Novel Fragment Library with Functional Complexity against Mycobacterium tuberculosis InhA.新型功能复杂性片段文库对结核分枝杆菌 InhA 的筛选。
ChemMedChem. 2018 Apr 6;13(7):672-677. doi: 10.1002/cmdc.201700774. Epub 2018 Feb 19.
8
Conformational flexibility of DENV NS2B/NS3pro: from the inhibitor effect to the serotype influence.登革病毒NS2B/NS3蛋白酶的构象灵活性:从抑制剂作用到血清型影响
J Comput Aided Mol Des. 2016 Mar;30(3):251-70. doi: 10.1007/s10822-016-9901-8. Epub 2016 Feb 29.
合理优化药物-靶标停留时间:抑制剂与金黄色葡萄球菌 FabI 酶-产物复合物结合的启示。
Biochemistry. 2013 Jun 18;52(24):4217-28. doi: 10.1021/bi400413c. Epub 2013 Jun 6.
4
Dynamics of Plasmodium falciparum enoyl-ACP reductase and implications on drug discovery.恶性疟原虫烯酰基 ACP 还原酶的动力学及其对药物发现的影响。
Protein Sci. 2012 Nov;21(11):1734-45. doi: 10.1002/pro.2155. Epub 2012 Oct 9.
5
Staphylococcus aureus FabI: inhibition, substrate recognition, and potential implications for in vivo essentiality.金黄色葡萄球菌 FabI:抑制、底物识别及对体内必需性的潜在影响。
Structure. 2012 May 9;20(5):802-13. doi: 10.1016/j.str.2012.03.013.
6
Targeting InhA, the FASII enoyl-ACP reductase: SAR studies on novel inhibitor scaffolds.靶向 InhA,即 FASII 烯酰基-ACP 还原酶:新型抑制剂骨架的 SAR 研究。
Curr Top Med Chem. 2012;12(7):672-93. doi: 10.2174/156802612799984535.
7
Conformational changes in 2-trans-enoyl-ACP (CoA) reductase (InhA) from M. tuberculosis induced by an inorganic complex: a molecular dynamics simulation study.结核分枝杆菌 2-反式烯酰-ACP(CoA)还原酶(InhA)的构象变化由无机配合物诱导:分子动力学模拟研究。
J Mol Model. 2012 May;18(5):1779-90. doi: 10.1007/s00894-011-1200-7. Epub 2011 Aug 12.
8
fconv: Format conversion, manipulation and feature computation of molecular data.fconv:分子数据的格式转换、操作和特征计算。
Bioinformatics. 2011 Apr 1;27(7):1021-2. doi: 10.1093/bioinformatics/btr055. Epub 2011 Feb 18.
9
The challenge of new drug discovery for tuberculosis.结核病新药研发面临的挑战。
Nature. 2011 Jan 27;469(7331):483-90. doi: 10.1038/nature09657.
10
POVME: an algorithm for measuring binding-pocket volumes.POVME:一种用于测量结合口袋体积的算法。
J Mol Graph Model. 2011 Feb;29(5):773-6. doi: 10.1016/j.jmgm.2010.10.007. Epub 2010 Nov 3.